基于双能量CT的预测模型用于预测临床淋巴结阴性甲状腺乳头状癌中央区淋巴结转移数目的建立与验证
本研究纳入2016年1月至2021年1月490例接受肺叶切除或甲状腺切除、中央区淋巴结清扫及术前双能量CT检查的临床淋巴结阴性甲状腺乳头状癌患者,随机分为训练队列345例和验证队列145例,建立并验证基于双能量CT参数和临床因素的列线图预测>5枚中央区淋巴结转移,训练队列AUC为0.842、验证队列AUC为0.848,均优于临床模型(AUC分别为0.688和0.694),列线图分层的高危与低危组无复发生存曲线有显著差异。
要点
- 年龄、肿瘤大小、动脉期标准化碘浓度、标准化有效原子序数和能谱Hounsfield单位曲线斜率是>5枚中央区淋巴结转移的独立预测因素。
- 基于双能量CT参数的列线图预测>5枚中央区淋巴结转移的训练队列AUC为0.842、验证队列AUC为0.848。
- 列线图分层的高危与低危组无复发生存曲线有显著差异。
核心结论
- 基于双能量CT参数和临床因素的列线图有助于术前预测临床淋巴结阴性甲状腺乳头状癌患者的中央区淋巴结转移数目。
研究设计与样本
- 研究纳入2016年1月至2021年1月490例接受肺叶切除或甲状腺切除、中央区淋巴结清扫及术前双能量CT检查的患者,随机分为训练队列345例和验证队列145例,收集临床特征和原发肿瘤的双能量CT定量参数,建立预测>5枚中央区淋巴结转移的模型。
诊断标准与关键数值
- >5枚中央区淋巴结转移在75例(15.3%)临床淋巴结阴性甲状腺乳头状癌患者中发现;年龄、肿瘤大小、动脉期标准化碘浓度、标准化有效原子序数和能谱Hounsfield单位曲线斜率为独立预测因素;列线图训练队列AUC为0.842、验证队列AUC为0.848,临床模型训练队列AUC为0.688、验证队列AUC为0.694。
临床应用与阅片要点
- 作者认为,基于双能量CT参数和临床因素的列线图可促进临床淋巴结阴性甲状腺乳头状癌患者中央区淋巴结转移数目的术前预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aimed to develop and validate a dual-energy CT (DECT)-based model for preoperative prediction of the number of central lymph node metastases (CLNMs) in clinically node-negative (cN0) papillary thyroid carcinoma (PTC) patients.
MATERIALS AND METHODS: Between January 2016 and January 2021, 490 patients who underwent lobectomy or thyroidectomy, CLN dissection, and preoperative DECT examinations were enrolled and randomly allocated into the training (N = 345) and validation cohorts (N = 145). The patients' clinical characteristics and quantitative DECT parameters obtained on primary tumors were collected. Independent predictors of> 5 CLNMs were identified and integrated to construct a DECT-based prediction model, for which the area under the curve (AUC), calibration, and clinical usefulness were assessed. Risk group stratification was performed to distinguish patients with different recurrence risks.
RESULTS: More than 5 CLNMs were found in 75 (15.3%) cN0 PTC patients. Age, tumor size, normalized iodine concentration (NIC), normalized effective atomic number (nZeff) and the slope of the spectral Hounsfield unit curve (λHu) in the arterial phase were independently associated with> 5 CLNMs. The DECT-based nomogram that incorporated predictors demonstrated favorable performance in both cohorts (AUC: 0.842 and 0.848) and significantly outperformed the clinical model (AUC: 0.688 and 0.694). The nomogram showed good calibration and added clinical benefit for predicting> 5 CLNMs. The KaplanMeier curves for recurrence-free survival showed that the high- and low-risk groups stratified by the nomogram were significantly different.
CONCLUSION: The nomogram based on DECT parameters and clinical factors could facilitate preoperative prediction of the number of CLNMs in cN0 PTC patients.
引用
- Chen, Lin, Cheng, et al. Development and Validation of a Dual-Energy CT-Based Model for Predicting the Number of Central Lymph Node Metastases in Clinically Node-Negative Papillary Thyroid Carcinoma. Acad Radiol. 2023. PMID: 37280128. doi:10.1016/j.acra.2023.04.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。